About this trial
The purpose of this study is to perform an open label feasibility trial of TMS for the treatment of chronic scrotal content pain.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male patients with chronic scrotal pain lasting for 6 or more months.
Pain must be present 3 or more days of the week.
Disqualifiers
No new pain medications within the last 30 days.
Trial design
Single group
Treatments tested in this trial
Transcranial magnetic stimulation
Other interventionResting motor threshold will be established by first finding the area of the motor cortex associated with visible twitch of the right abductor pollicis brevis (APB). Parameter Estimation by Sequential Testing (PEST) will be conducted to quantify resting motor threshold using visible APB twitch. The left dorsolateral prefrontal cortex (DLPFC) will be located using the Beam F3 method and marked with a felt-tipped marker on the scalp. TMS will be delivered over left DLPFC at 110% of resting motor threshold at 10Hz (5-seconds-on; 10-seconds-off) for 15 minutes per session (3000 pulses), 3 sessions each day (30-minute rest in-between sessions), for 3 days (within 5 consecutive days; a total of 27,000 pulses).
Treatment groups
Trial outcomes
Primary outcomes
Patient reported pain score on SMS text EMA system
A custom developed SMS text EMA system will be used to gather daily data on pain
Secondary outcomes
Patient reported post procedure quality of life as measured on an SMS text EMA system
A custom developed SMS text EMA system will be used to gather daily data on pain
Progression to other treatments
Progression to other medical or surgical treatments
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: